Neurogene (NGNE) Institutional Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free NGNE Stock Alerts $32.50 -0.71 (-2.14%) (As of 04:00 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Neurogene (NASDAQ:NGNE)CurrentInstitutional OwnershipPercentage52.37%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$29.20MNumber ofInstitutional Sellers(last 12 months)0 Get NGNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NGNE Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Neurogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2024 SG Americas Securities LLC2,348$120K0.0%N/A0.018% 4/30/2024 Privium Fund Management UK Ltd5,860$274K0.1%N/A0.046% 2/15/2024Great Point Partners LLC994,229$19.27M3.3%N/A42.326% 2/14/2024Avidity Partners Management LP466,243$9.04M0.3%N/A19.840% 2/2/2024 BML Capital Management LLC24,666$478K0.4%N/A1.050% (Data available from 1/1/2016 forward) NGNE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NGNE shares? During the previous two years, the following institutional investors and hedge funds held shares of Neurogene shares: Great Point Partners LLC ($19.27M), Avidity Partners Management LP ($9.04M), BML Capital Management LLC ($478K), and Privium Fund Management UK Ltd ($274K), SG Americas Securities LLC ($120K).Learn more on NGNE's institutional investors. What percentage of Neurogene stock is owned by institutional investors? 52.37% of Neurogene stock is owned by institutional investors. Learn more on NGNE's institutional investor holdings. Which institutional investors have been buying Neurogene stock? The following institutional investors have purchased Neurogene stock in the last 24 months: Great Point Partners LLC ($994.23K), Avidity Partners Management LP ($466.24K), BML Capital Management LLC ($24.67K), Privium Fund Management UK Ltd ($5.86K), and SG Americas Securities LLC ($2.35K). How much institutional buying is happening at Neurogene? Institutional investors have bought a total of 1,493,346 shares in the last 24 months. This purchase volume represents approximately $29.20M in transactions. Related Companies: ANL Major Shareholders TBPH Major Shareholders FULC Major Shareholders KRRO Major Shareholders PEPG Major Shareholders LXRX Major Shareholders TVTX Major Shareholders TRDA Major Shareholders BMEA Major Shareholders ANNX Major Shareholders This page (NASDAQ:NGNE) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.